ETC
COLL icon

Exchange Traded Concepts’s Collegium Pharmaceutical COLL Stock Holding History

Exchange Traded Concepts’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Buy
58,267
+834
+1% +$28.5K 0.01% 700
2026
Q1 		$1.9M Buy
57,433
+36,966
+181% +$1.57M 0.01% 627
2025
Q4 		$948K Sell
20,467
-600
-3% -$25.1K 0.01% 831
2025
Q3 		$737K Sell
21,067
-44,065
-68% -$1.53M 0.01% 930
2025
Q2 		$1.93M Buy
65,132
+2,706
+4% +$77.2K 0.02% 493
2025
Q1 		$1.86M Sell
62,426
-12,669
-17% -$387K 0.03% 392
2024
Q4 		$2.15M Buy
75,095
+3,402
+5% +$113K 0.04% 357
2024
Q3 		$2.77M Buy
71,693
+5,469
+8% +$195K 0.06% 252
2024
Q2 		$2.13M Buy
66,224
+3,695
+6% +$128K 0.05% 279
2024
Q1 		$2.43M Buy
+62,529
New +$2.19M 0.06% 265
2023
Q1 		– Sell
-77,435
Closed -$1.8M – 1165
2022
Q4 		$1.8M Buy
77,435
+2,364
+3% +$47.7K 0.05% 196
2022
Q3 		$1.2M Sell
75,071
-1,402
-2% -$24.7K 0.04% 228
2022
Q2 		$1.35M Buy
76,473
+2,278
+3% +$38.3K 0.04% 235
2022
Q1 		$1.51M Buy
74,195
+50,785
+217% +$960K 0.03% 256
2021
Q4 		$437K Buy
23,410
+423
+2% +$8.25K 0.01% 712
2021
Q3 		$454K Buy
+22,987
New +$497K 0.01% 658

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Exchange Traded Concepts's COLL Position: Q2 2026 in Review

Exchange Traded Concepts increased its Collegium Pharmaceutical (COLL) stake by 1.5% in Q2 2026, buying an estimated $28.5K and bringing the position to 58,267 shares worth $2.11M. The position accounts for 0.01% of the portfolio, ranked #700.

Exchange Traded Concepts first reported a position in COLL in Q3 2021 and has held it in 16 quarters since. The position peaked at $2.77M in Q3 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Exchange Traded Concepts held 58,267 shares of Collegium Pharmaceutical worth $2.11M as of Q2 2026.
  • Exchange Traded Concepts bought 834 Collegium Pharmaceutical shares in Q2 2026, an estimated $28.5K.
  • Collegium Pharmaceutical made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #700 holding.
  • Exchange Traded Concepts first reported a position in Collegium Pharmaceutical in Q3 2021 and has held it in 16 quarters since.
  • Exchange Traded Concepts's Collegium Pharmaceutical position peaked at $2.77M in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.